Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniae
The mutant prevention concentration (MPC) represents a threshold above which the selective proliferation of resistant mutants is expected to occur only rarely. A provisional MPC (MPC(pr)) was defined and measured for five fluoroquinolones with clinical isolates of Streptococcus pneumoniae. Based on...
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology (ASM)
2001
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90309/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11158737/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.2.433-438.2001 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|